Sjögren’s patient subgroups identified through whole genome DNA methylation profiling

Key Points

• The study identifies distinct subgroups of Sjögren's patients based on unique DNA methylation patterns, improving the understanding of this condition.
• Key evidence reveals multiple biomarkers associated with Sjögren's syndrome that can enhance diagnosis and treatment options.
• Utilizing genome profiling techniques, the analysis highlights significant differences among patient subgroups revealed through DNA methylation.
• These findings support the notion that personalized treatment approaches may better address the varied manifestations of Sjögren's syndrome.